Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed)
ID: 344458Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/344458

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-023.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced the Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01), aimed at supporting individuals engaged in research that informs the Food and Drug Administration's (FDA) regulations on tobacco products. This grant provides funding for up to five years of supervised career development, specifically excluding independent clinical trials, and focuses on enhancing understanding of tobacco product implications through innovative research in areas such as product composition, toxicity, and health effects. With a total funding amount of $500,000 available for three awards, eligible applicants must demonstrate strong research and mentoring environments and align their projects with FDA regulatory priorities. Interested parties can find more information and submission guidelines at the provided NIH link, with applications due by March 12, 2025.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-OD-22-023.html
    The Department of Health and Human Services has issued a funding opportunity announcement (FOA) for the Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01). This program targets individuals pursuing research to inform FDA regulations on tobacco products under the Family Smoking Prevention and Tobacco Control Act. Funding supports up to five years of supervised career development, specifically excluding independent clinical trials. The NIH and FDA are collaborating to enhance understanding of tobacco product implications through innovative research. Key objectives include investigating product composition, toxicity, addiction, health effects, behavior, communication, and marketing influences. The awards aim to foster a diverse pool of scientists committed to tobacco regulatory science, with funding totaling $500,000 for three awards. Eligible applicants must demonstrate strong research and mentoring environments, commitment to career independence, and alignment with FDA's regulatory priorities. Applications must adhere to specific submission guidelines, and candidates are encouraged to engage with mentors who possess extensive expertise in tobacco research. This FOA underscores the government's commitment to public health through rigorous research that informs tobacco regulation, ensuring evidence-based approaches in addressing tobacco-related issues.
    Similar Opportunities
    Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01) to support intensive career development in research related to tobacco regulations. This grant aims to provide funding for projects that will inform the development and evaluation of regulations on tobacco product manufacturing, distribution, and marketing, in alignment with the FDA's regulatory authority under the Family Smoking Prevention and Tobacco Control Act. Eligible applicants include various higher education institutions and nonprofit organizations, with awards providing up to $90,000 annually for salary and $60,000 for research-related expenses. Interested applicants must submit their proposals by March 12, 2025, and can find additional information and application details at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required )
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Pathway to Independence Award in Tobacco Regulatory Research (K99/R00), aimed at fostering a new generation of independent researchers focused on tobacco regulation under the FDA's jurisdiction. This grant supports postdoctoral researchers in transitioning to independent faculty positions through a two-phase program: the K99 phase provides up to two years of mentored training, while the R00 phase offers up to three years of independent research funding, with a total funding commitment of $750,000 for approximately five awards. Eligible applicants must have no more than four years of postdoctoral experience and are encouraged to align their proposals with FDA scientific domains, addressing critical issues such as product composition, health effects, and marketing influences. Interested candidates should submit their applications by March 12, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Pathway to Independence Award in Tobacco Regulatory Research (K99/R00), aimed at fostering a new generation of independent researchers in the field of tobacco regulation. This grant program is designed to support postdoctoral researchers transitioning to independent faculty positions, with a focus on research that informs the regulation of tobacco products as mandated by the Family Smoking Prevention and Tobacco Control Act. The K99 phase provides up to two years of mentored research training, followed by the R00 phase, which offers up to three years of independent research support, targeting areas such as tobacco product composition, health effects, addiction, and the evaluation of FDA regulatory actions. Applications are due periodically, with the next deadlines on November 14, 2023, and March 12, 2025. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    High-Priority Research in Tobacco Regulatory Science (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for "High-Priority Research in Tobacco Regulatory Science" aimed at advancing scientific understanding of tobacco products to inform regulations by the Food and Drug Administration (FDA). This initiative invites R01 applications focused on critical research areas, including addiction, health impacts, and the toxicity of electronic nicotine delivery systems (ENDS) and other tobacco products. The funding is crucial for generating data that will guide FDA's regulatory decisions, ultimately protecting public health. Each application can request up to $500,000 per year for a project period of up to five years, with a total of $4 million available across five awards. Applications are due by June 7, 2025, and interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Tobacco Regulatory Science (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Tobacco Regulatory Science (R01 Clinical Trial Optional)" funding opportunity, aimed at supporting biomedical and behavioral research to inform the regulation of tobacco products and protect public health. This initiative seeks R01 research project grant applications that address key research priorities, including the composition and design of tobacco products, toxicity assessments, addiction studies, and the health effects of tobacco use. A total of up to six R01 grants, with a combined funding of $4 million for fiscal year 2024, will be awarded to eligible applicants, which include a diverse range of institutions and organizations. Interested parties should submit their applications by May 4, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-23-017.html for further details.
    Notice of Intent to Publish a Notice of Funding Opportunity (NOFO) for High-Priority Research in Tobacco Regulatory Science (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for High-Priority Research in Tobacco Regulatory Science, inviting R01 research applications that focus on biomedical and behavioral research to inform tobacco product regulation. This initiative aims to generate scientific data that will enhance public health protections related to tobacco use, with a particular emphasis on fostering diverse perspectives through a simplified peer review framework. The total estimated funding for this program is $4 million, with an award ceiling of $500,000 for each of the anticipated five awards, and the NOFO is expected to be published in Winter 2024, with applications due in Summer 2025. Interested applicants should prepare to submit new applications, as only new proposals will be considered, and further details will be available upon the official release of the NOFO.
    Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Mentored Clinical Scientist Research Career Development Award (K08), aimed at supporting individuals with clinical doctoral degrees in their pursuit of a research career in health-related fields. This grant provides salary and research support for a duration of 3-5 years, focusing on developing candidates' skills in biomedical and behavioral research while prohibiting independent clinical trial proposals. The program emphasizes the importance of mentorship and institutional support, encouraging applications from diverse eligible institutions, including Historically Black Colleges and Universities (HBCUs) and other minority-serving organizations. Interested applicants should note that the application deadline is May 7, 2027, and can find additional details and guidelines at the NIH grants website or by contacting NIH Grants Information at grantsinfo@nih.gov.
    Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Mentored Patient-Oriented Research Career Development Award (Parent K23), a federal grant aimed at supporting the career development of clinical researchers dedicated to patient-oriented research. Applicants must possess a clinical doctoral degree and demonstrate prior training and potential for research success, with a focus on leading independent clinical trials or related studies. This initiative is crucial for fostering a new generation of qualified clinical researchers to address pressing health needs, providing essential resources such as mentorship and funding over a period of 3-5 years. Interested applicants can find more information and apply by visiting the NIH grants website, with the application deadline set for May 7, 2027. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    The NCI Transition Career Development Award (K22 Independent Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Transition Career Development Award (K22), a federal grant aimed at supporting researchers transitioning from mentored, non-independent positions to their first independent tenure-track faculty roles in cancer research. This grant provides funding for up to three years, covering both salary and research development expenses, with the goal of enhancing the applicant's potential to secure independent NIH grants and fostering a diverse pool of capable scientists in the biomedical field. Eligible applicants include various institutions and organizations, particularly those serving underrepresented groups, and must adhere to detailed application guidelines. Interested parties can find more information and apply before the closing date of November 12, 2025, by visiting the NIH grants website or contacting NIH Grants Information at grantsinfo@nih.gov.
    Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Mentored Research Scientist Development Award (K01), a federal grant aimed at supporting individuals in their pursuit of research independence in the biomedical, behavioral, or clinical sciences. This grant provides funding for a protected period of three to five years, allowing candidates to develop their research careers under the mentorship of experienced professionals, specifically focusing on basic experimental studies involving human participants. The program is designed to foster a diverse cohort of capable scientists to address national research needs, with applications opening on May 12, 2024, and deadlines extending through 2025. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.